Clinical trial
Creatine Supplementation for CBS-related Homocystinuria: A Proof-of-concept Study in Healthy Adults
NCT06495567 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Creatine Supplementation for CBS-related Homocystinuria: A Proof-of-concept Study in Healthy Adults
- Lead sponsor
- University of British Columbia
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 19, 2024
- Completion date
- December 1, 2026
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.